Pharmapark — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Pharmapark is a private, revenue-generating Russian biopharmaceutical company established in 2003, operating as a full-cycle developer and manufacturer of biological drugs. It has a diversified business model combining proprietary in-house product development with extensive contract manufacturing and localization services for international partners. The company's strategy leverages its GMP-certified production facilities, R&D center, and a network of global partnerships to bring both generic and original biologics to the Russian market and beyond.

OncologyAutoimmune DiseasesInfectious DiseasesNephrologyHematology

Technology Platform

Integrated GMP biomanufacturing platform with prokaryotic and eukaryotic expression systems, dedicated monoclonal antibody production line, and in-house R&D center focused on development and scalable production technology for biological drugs.

Opportunities

Pharmapark is strongly positioned to benefit from Russia's pharmaceutical import substitution policies, creating sustained demand for local production of complex biologics.

Its growing partnerships with Asian biotech firms provide a pipeline of modern drugs for localization, while its contract manufacturing capabilities offer a diversified revenue stream in a supply-constrained region.

Risk Factors

The company faces severe geopolitical risks, including international sanctions that can disrupt supply chains and isolate it from Western technology and capital.

Operational success depends heavily on executing complex technology transfers with partners and navigating an increasingly volatile domestic economic and regulatory environment.

Competitive Landscape

Pharmapark competes with other large Russian pharma holdings (e.g., Pharmstandard, Generium) in the biologics space, as well as with multinational corporations importing drugs. Its key differentiator is its integrated full-cycle model combining development, GMP manufacturing, and localization services specifically tailored for the Russian market and international partners seeking access to it.

More companies in Europe - Other →